[ACRX] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
16-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -13.29%
YoY- -14.85%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 1,368 2,924 386 475 608 941 265 197.80%
PBT -8,930 -6,602 -15,925 -14,423 -12,731 -12,409 -13,674 -24.66%
Tax 931 4 843 885 1,212 3 627 30.05%
NP -8,930 -6,606 -15,925 -14,423 -12,731 -12,412 -13,674 -24.66%
Tax Rate - - - - - - - -
Total Cost 10,298 9,530 16,311 14,898 13,339 13,353 13,939 -18.23%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -652.78 -225.92 -4,125.65 -3,036.42 -2,093.91 -1,319.02 -5,160.00 -74.70%
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -2.03 -1.64 -3.98 -3.63 -3.20 -3.15 -3.47 -29.98%
EPS Diluted -2.03 -1.64 -3.98 -3.63 -3.20 -3.15 -3.47 -29.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.